We came across a bullish thesis on Niagen Bioscience, Inc. on Ridire Research’s Substack. In this article, we will summarize the bulls’ thesis on NAGE. Niagen Bioscience, Inc.'s share was trading at $65.99 as of January 29th. NAGE’s trailing and forward P/E were 24.96 and 19.96 respectively according to Yahoo Finance.
[caption id="attachment_564437" align="aligncenter" width="750"]Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. NAGE formerly ChromaDex, represents the purest...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.